Klee GG - Search Results

1

A systematic method for selection of promising serum protein biomarkers to improve prostate cancer (PCa1) detection.

Finlay JA, Klee EW, McDonald C, Attewell JR, Hebrink D, Dyer R, Love B, Vasmatzis G, Li TM, Beechem JM, Klee GG. Finlay JA, et al. Among authors: klee ew, klee gg. Clin Chem. 2006 Nov;52(11):2159-62. doi: 10.1373/clinchem.2006.072959. Clin Chem. 2006. PMID: 18061988 No abstract available.

2

Bioinformatics methods for prioritizing serum biomarker candidates.

Klee EW, Finlay JA, McDonald C, Attewell JR, Hebrink D, Dyer R, Love B, Vasmatzis G, Li TM, Beechem JM, Klee GG. Klee EW, et al. Among authors: klee gg. Clin Chem. 2006 Nov;52(11):2162-4. doi: 10.1373/clinchem.2006.072868. Clin Chem. 2006. PMID: 18061989 No abstract available.

3

Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood.

Klee EW, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ, Bergen HR 3rd, Sebo TJ, Klee GG. Klee EW, et al. Among authors: klee gg. Clin Chem. 2012 Mar;58(3):599-609. doi: 10.1373/clinchem.2011.171637. Epub 2012 Jan 12. Clin Chem. 2012. PMID: 22247499 Free PMC article.

4

LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer.

Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. Bondar OP, et al. Among authors: klee ew, klee gg. Clin Chem. 2007 Apr;53(4):673-8. doi: 10.1373/clinchem.2006.079681. Epub 2007 Feb 22. Clin Chem. 2007. PMID: 17317883

5

Development of a dual monoclonal antibody immunoassay for total human kallikrein 2.

Finlay JA, Day JR, Evans CL, Carlson R, Kuus-Reichel K, Millar LS, Mikolajczyk SD, Goodmanson M, Klee GG, Rittenhouse HG. Finlay JA, et al. Among authors: klee gg. Clin Chem. 2001;47(7):1218-24. Clin Chem. 2001. PMID: 11427452

6

Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2.

Klee GG, Goodmanson MK, Jacobsen SJ, Young CY, Finlay JA, Rittenhouse HG, Wolfert RL, Tindall DJ. Klee GG, et al. Clin Chem. 1999 Jun;45(6 Pt 1):800-6. Clin Chem. 1999. PMID: 10351988 Clinical Trial.

7

Global methylation profiling for risk prediction of prostate cancer.

Mahapatra S, Klee EW, Young CY, Sun Z, Jimenez RE, Klee GG, Tindall DJ, Donkena KV. Mahapatra S, et al. Among authors: klee ew, klee gg. Clin Cancer Res. 2012 May 15;18(10):2882-95. doi: 10.1158/1078-0432.CCR-11-2090. Clin Cancer Res. 2012. PMID: 22589488

8

Immunological and mass spectrometric assays of SHBG: consistent and inconsistent metabolic associations in healthy men.

Veldhuis JD, Bondar OP, Dyer RB, Trushin SA, Klee EW, Singh RJ, Klee GG. Veldhuis JD, et al. Among authors: klee ew, klee gg. J Clin Endocrinol Metab. 2014 Jan;99(1):184-93. doi: 10.1210/jc.2013-2642. Epub 2013 Dec 20. J Clin Endocrinol Metab. 2014. PMID: 24203061 Free PMC article.

9

Mass spectrometry measurements of prostate-specific antigen (PSA) peptides derived from immune-extracted PSA provide a potential strategy for harmonizing immunoassay differences.

Klee EW, Bondar OP, Goodmanson MK, Trushin SA, Singh RJ, Anderson NL, Klee GG. Klee EW, et al. Among authors: klee gg. Am J Clin Pathol. 2014 Apr;141(4):527-33. doi: 10.1309/AJCP8PEL0YXAHDVK. Am J Clin Pathol. 2014. PMID: 24619754

10

Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.

Charlesworth MC, Young CY, Klee GG, Saedi MS, Mikolajczyk SD, Finlay JA, Tindall DJ. Charlesworth MC, et al. Among authors: klee gg. Urology. 1997 Mar;49(3):487-93. doi: 10.1016/s0090-4295(96)00620-6. Urology. 1997. PMID: 9123724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page